Navigation Links
MiMedx Group Announces Third Quarter 2011 Results
Date:10/26/2011

tissue beyond tendonitis applications, the effect of in-process clinical evaluations on the Company's reimbursement efforts and the outcome of these evaluations, the effectiveness of the Company's management team in educating health plans on the clinical and cost effectiveness of the Company's tissues, the Company's OEM business opportunities and its ability to bring OEM relationships online during the fourth quarter, the attainment of a Medicare reimbursement code for use by certain facilities using the Company's products and the resultant effect on demand for the Company's products, the prospect of receiving the CE Mark regulatory clearance for the Company's  first CollaFix™ product during the fourth quarter, the demand for the product once cleared and the Company's preparedness for ramping up production to meet anticipated demand. These statements are based on current information and belief, and are not guarantees of future performance.  Among the risks and uncertainties that could cause actual results to differ materially from those indicated by such forward-looking statements include that the Company may not achieve expected revenue growth or realize anticipated cost savings and may not achieve and/or  be able to sustain positive Adjusted EBITDA in the near term or at all;  that potential new uses for the Company's amniotic membrane injectable tissue may not materialize, that results of the in-process clinical evaluations will not be as anticipated or will not have the anticipated impact on the Company's reimbursement efforts, that the OEM business opportunities may not materialize as expected and the Company may be unable to bring additional OEM relationships online during the fourth quarter, that the Company many not receive a Medicare reimbursement code for its products or that the receipt of a Medicare reimbursement code does not increase demand for the Company's products, that the Company may not receive anticipated regulatory cl
'/>"/>
SOURCE MiMedx Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. MiMedx Groups EpiFix® Receives American Podiatric Medical Association Seal of Approval
2. MiMedx Group Partners With Affirmative Solutions
3. MiMedx Group Receives FDA Clearance to Market Its HydroFix™ Ortho Shield™ Device
4. MiMedx Announces Launch of AmnioFix™ Nerve Wrap
5. MiMedx to Attend International Society for the Advancement of Spine Surgery Annual Meeting
6. MiMedx Group, Inc. Announces Release Date for First Quarter Results
7. MiMedx Completes Acquisition of Surgical Biologics
8. MiMedx Receives Additional CE Certification for Its HydroFix™ Technology
9. MiMedx Announces Agreement to Acquire Surgical Biologics
10. MiMedx Group, Inc. Announces Release Date for Second Quarter Results
11. MiMedx Group Announces Addition of Sales Director for Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... YORK , Feb. 27, 2015 Securities ... the board of Salix Pharmaceuticals, Ltd. (NASDAQ: ... $158.00 per share. Concerned SLXP investors are encouraged to ... The investigation focuses upon the shareholder ... agreement, Salix shareholders would receive only $158.00 per share ...
(Date:2/27/2015)... February 27, 2015 Report Details ... showing you trends, R&D progress, and predicted revenues ,Where ... What are the commercial prospects for this market and ... revenues and other trends to 2025, discussing data, opportunities ... you assess regenerative medicine : cell-based therapies that ...
(Date:2/27/2015)... DIEGO , Feb. 27, 2015  Organovo ... biology company focused on delivering breakthrough 3D bioprinting ... President and Chief Executive Officer, will present live ... "We invite you to join us for this ... provide updates on our commercial launch of the ...
Breaking Medicine Technology:Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 2Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 3Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 4
... Md., Jan. 27, 2012 GenVec, Inc. (Nasdaq: ... technologies to create superior therapeutics and vaccines, today announced ... Agreement with Novartis (NYSE: NVS).  Under the extension, Novartis ... support its hearing loss and balance disorders program. ...
...  Allscripts is taking a leading role in facilitating ... patients with cardiovascular diseases through sponsorship of the ... (Logo:  http://photos.prnewswire.com/prnh/20100901/CG58147LOGO ) ... year by the U.S. Department of Health & ...
Cached Medicine Technology:GenVec Extends Research Collaboration with Global Pharmaceutical Company 2GenVec Extends Research Collaboration with Global Pharmaceutical Company 3Allscripts Invites Developers to Million Hearts Initiative 2Allscripts Invites Developers to Million Hearts Initiative 3Allscripts Invites Developers to Million Hearts Initiative 4
(Date:2/28/2015)... In a recent episode of SCI ... Change Athlete Development Services and Consultancy talks with ... athlete development and player engagement during and after their ... athletes face and how off-field activities are a critical ... involved in athlete development issues while in graduate school ...
(Date:2/28/2015)... March—also known as National Brain Injury ... and others that suspected head injuries, especially concussions, ... , Concussions are a form of traumatic brain ... There are 1.6-3.8 million sports-related concussions per year. ... is a brain injury. Many athletes suffer knee ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 For those ... in person, the Mesothelioma Applied Research Foundation ... on Tuesday, March 3, starting at 9:30 AM. , ... no registration. The broadcast can be accessed through any ... http://www.curemeso.org/symposium . , The Symposium is a unique event ...
(Date:2/28/2015)... FL (PRWEB) February 28, 2015 ... organization has sponsored visitor health insurance programs for visitors ... years. Most Indian elderly parents traveling to the United ... such as diabetes and blood pressure. These diseases are ... not even list them as medical conditions. There were ...
(Date:2/28/2015)... February 28, 2015 The noted Friedman ... that they have officially relaunched their website. The new ... but it contains a new section about their team ... read the full biographies of each Friedman Dental Group ... the website was designed to provide our patients with ...
Breaking Medicine News(10 mins):Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3Health News:Friedman Dental Group Announces Their Updated Website 2
... Institute of Medical Sciences (AIIMS) here died Saturday of dengue ... control spread of the deadly fever in the campus. ... AIIMS after he had tested positive for dengue Thursday. His ... brain haemorrhage. ,"Kiran, a native of Hyderabad and ...
... A report has found that prices of 200 brand name drugs ... during the 12 month period ending // mid June 2006, against ... and reported in their Rx Watchdog Report released on Tuesday. It ... drugs remain the same. ,Heading the list of drugs ...
... by physicians experienced with the technique//, and pain reduction ... multi-center cohort study. ,Among the 25 patients enrolled ... a 10-point visual analog scale was 7.3 at baseline, ... 24 weeks, and 0.3 at 52 weeks, according to ...
... member Tom Mayer, MD, and colleagues studied 1,200 patients ... most were using substantial amounts of opioids when they ... drugs by graduation. One year later, however, 15% were ... patient would be out of work, and doubled the ...
... School Of Medicine have shown for the first time ... muscle mass or for replacement therapy//, which results in ... to a appalling loss of brain cells. ,High ... cause hyper excitability, volatile and violent nature, and suicidal ...
... Laws that require minors to notify or get the consent ... risky sexual behavior among teens//, according to a Florida State ... Jeffrey A. Stoops Professor of Law, and Thomas Stratmann, professor ... after they looked at the rates of gonorrhea among teenage ...
Cached Medicine News:Health News:AIIMS Student Dies of Dengue Fever 2Health News:Brand Name Drug Prices Zoom 2Health News:Sacroplasty Safe and Effective to Reduce Low Back Pain 2Health News:Sacroplasty Safe and Effective to Reduce Low Back Pain 3Health News:Opioids Linked to Worse Outcomes After Back Injury 2Health News:Abortion Notification, Consent Laws Reduce Risky Teen Sex 2
AccuSign DOA Series tests include tests for Amphetamines, Barbituates, Benzodiazepines, Cocaine, Methadone, Methamphetamines, Nicotine (Cotinine), Opiates, Phencyclidine, THC, Tricyclic Antidepressan...
Accu-Stat Home Drug Test for Marijuana (THC), Cocaine (COC), Amphetamine (AMP), Methamphetamine (mAMP), Opiates (OPI), and Phencyclidine (PCP)....
... multi-drug test device provides clear, ... Negative results can be determined ... minutes; positive results require only ... urine sample application will dependably ...
... The ADC drugs of abuse tests are highly ... the SAMHSA recommended cut-off as confirmed by GC/MS ... A more specific alternative method (such as GC/MS) ... confirmed result. Professional judgment should be applied to ...
Medicine Products: